[Progress in the diagnosis and therapy of trophoblastic tumors].
D000293:Adolescent; D000328:Adult; D000963:Antimetabolites / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002822:Choriocarcinoma; D003609:Dactinomycin / Q000627:therapeutic use; D005260:Female; D005493:Folic Acid Antagonists / Q000627:therapeutic use; D006801:Humans; D006828:Hydatidiform Mole; D006834:Hydrazines / Q000627:therapeutic use; D015122:Mercaptopurine / Q000627:therapeutic use; D008727:Methotrexate / Q000627:therapeutic use; D008875:Middle Aged; D009362:Neoplasm Metastasis; D011247:Pregnancy; D011248:Pregnancy Complications; D014328:Trophoblastic Neoplasms / Q000175:diagnosis* / Q000188:drug therapy*; D014747:Vinblastine / Q000627:therapeutic use
D000963:Antimetabolites; D000970:Antineoplastic Agents; D005493:Folic Acid Antagonists; D006834:Hydrazines; D003609:Dactinomycin; D014747:Vinblastine; D015122:Mercaptopurine; D008727:Methotrexate
Progressi nella diagnosi e nella terapia dei tumori trofoblastici.